Pikas vaccine - PEMULIH Assistance Package 2021

This gives them some freedom from social restrictions.

Preclinical studies have demonstrated that PIKA recombinant COVID-19 vaccine is capable of inducing rapid and efficient production of neutralizing antibody and cellular immunity against the currently prevalent virus variants of SARS-CoV-2, including the alpha, beta, gamma and delta variants from the United Kingdom, South Africa, Brazil and India.

Of the six COVID-related admissions, five were vaccinated and one patient was not vaccinated.

Miti in collaboration with the Special Committee for Ensuring Access to Covid-19 Vaccine Supply JKJAV and the Covid-19 Immunisation Task Force CITF are redoubling efforts to increase the number of existing Pikas PPVs to increase vaccination among the workforce in the manufacturing sector in Malaysia.